Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer.

Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer.
复制标题

DOI:
10.3389/fimmu.2018.02030
复制
发表时间:
2018
影响因子:
7.3
通讯作者:
Ngwa W
Ngwa W
中科院分区:
医学2区
文献类型:
--
作者:
Yasmin-Karim S;Bruck PT;Moreau M;Kunjachan S;Chen GZ;Kumar R;Grabow S;Dougan SK;Ngwa W

文献摘要

参考文献

被引文献

相似文献

放射治疗诱导免疫原性细胞死亡,理论上可以刺激T细胞引发和诱导肿瘤特异性记忆T细胞应答,作为原位疫苗。在实践中,这种远位效应很少观察到。我们使用两种胰腺癌小鼠模型来证明单剂量立体定向体部放射治疗(SBRT)与肿瘤内注射激动性抗CD40协同作用,导致未治疗的对侧肿瘤消退和长期免疫记忆的形成。当小鼠接受SBRT的多个部分时,或当TGFβ阻断与SBRT组合时,未观察到长期存活。SBRT和抗CD40在增强T细胞引发方面是如此有效,以至于诱导了对肿瘤和自身抗原的记忆性CD8 T细胞应答,导致长期存活者患上白癜风。
Radiation therapy induces immunogenic cell death, which can theoretically stimulate T cell priming and induction of tumor-specific memory T cell responses, serving as an in situ vaccine. In practice, this abscopal effect is rarely observed. We use two mouse models of pancreatic cancer to show that a single dose of stereotactic body radiation therapy (SBRT) synergizes with intratumoral injection of agonistic anti-CD40, resulting in regression of non-treated contralateral tumors and formation of long-term immunologic memory. Long-term survival was not observed when mice received multiple fractions of SBRT, or when TGFβ blockade was combined with SBRT. SBRT and anti-CD40 was so effective at augmenting T cell priming, that memory CD8 T cell responses to both tumor and self-antigens were induced, resulting in vitiligo in long-term survivors.
DOI: 10.1056/nejmoa1003466
发表时间: 2010-08-19
期刊: The New England journal of medicine
影响因子: --
作者:
Hodi FS;O'Day SJ;McDermott DF;Weber RW;Sosman JA;Haanen JB;Gonzalez R;Robert C;Schadendorf D;Hassel JC;Akerley W;van den Eertwegh AJ;Lutzky J;Lorigan P;Vaubel JM;Linette GP;Hogg D;Ottensmeier CH;Lebbé C;Peschel C;Quirt I;Clark JI;Wolchok JD;Weber JS;Tian J;Yellin MJ;Nichol GM;Hoos A;Urba WJ
通讯作者: Urba WJ
DOI: 10.3389/fimmu.2017.01547
发表时间: 2017
影响因子: 7.3
作者:
Dougan M
通讯作者: Dougan M
DOI: 10.1016/j.celrep.2015.04.031
发表时间: 2015-05-19
期刊: Cell reports
影响因子: 8.8
作者:
Corrales L;Glickman LH;McWhirter SM;Kanne DB;Sivick KE;Katibah GE;Woo SR;Lemmens E;Banda T;Leong JJ;Metchette K;Dubensky TW Jr;Gajewski TF
通讯作者: Gajewski TF
DOI: 10.1158/1078-0432.ccr-16-0870
发表时间: 2017-01-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Kalbasi A;Komar C;Tooker GM;Liu M;Lee JW;Gladney WL;Ben-Josef E;Beatty GL
通讯作者: Beatty GL
DOI: 10.1158/1078-0432.ccr-09-0265
发表时间: 2009-09-01
期刊: Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子: --
作者:
Dewan MZ;Galloway AE;Kawashima N;Dewyngaert JK;Babb JS;Formenti SC;Demaria S
通讯作者: Demaria S